Market accessOfficial
AIFA publishes sunset clause pre-notice for medicines facing lapse in early 2027
🇮🇹 AIFA · Tue 17 Nov 2026
Italy's medicines agency has issued a warning listing products at potential risk of losing their marketing authorisation for non-marketing, with lapse dates between January and March 2027.
The Italian Medicines Agency (AIFA) published a sunset clause pre-notice on 17 November 2026. It lists medicinal products potentially facing lapse of their marketing authorisation because they have not been marketed.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.
More Market access
All →
EEA Joint Committee adds six EU feed additive acts to Annex I of EEA Agreement
🇪🇺 EUR-Lex · Thu 19 Nov 2026
Health Canada flags Beckman Coulter DxC 500i software fault that may distort chemistry results
🇨🇦 Health Canada · Wed 18 Nov 2026
CMS moves Alimetry's Gastric Alimetry test to higher Medicare outpatient payment tier for 2027
Alimetry Inc. · Wed 18 Nov 2026
ANSM amends French generic groups directory in decision dated 12 November 2026
🇫🇷 ANSM · Wed 18 Nov 2026
Slovenia asks wholesalers to import estradiol 50 microgram patches amid supply disruption
🇸🇮 JAZMP · Wed 18 Nov 2026
SÚKL explains why Czech pharmacies may split repeat-prescription dispensing across days
🇨🇿 SÚKL · Wed 18 Nov 2026